ProfileGDS5678 / 1439742_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 47% 43% 43% 41% 48% 44% 51% 42% 41% 42% 43% 41% 43% 42% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.1591447
GSM967853U87-EV human glioblastoma xenograft - Control 22.9887643
GSM967854U87-EV human glioblastoma xenograft - Control 32.9942143
GSM967855U87-EV human glioblastoma xenograft - Control 42.8944241
GSM967856U87-EV human glioblastoma xenograft - Control 53.0956748
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.1166544
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.3065151
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.9647142
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.9273241
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.9510742
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.9796143
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.9217341
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.0078943
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.9749742